In HNSCC, we previously established the differential expression profile of alternative splicing through analysis of The Cancer Genome Atlas (TCGA) RNA sequencing data and validated that a novel DOCK5 splicing variant promoted the proliferation, migration and invasion of HNSCC cells [15]. The gene discussed is DOCK5; the disease is head and neck squamous cell carcinoma.